凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
泰合健康(000790)公告正文

泰合健康:2016年第三季度报告全文

公告日期 2016-10-18
股票简称:泰合健康 股票代码:000790
               成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文




成都泰合健康科技集团股份有限公司

       2016 年第三季度报告

             2016-074




          2016 年 10 月




                                                                     1
                                 成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文




                         第一节 重要提示


    公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真

实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和

连带的法律责任。

    所有董事均已出席了审议本次季报的董事会会议。

    公司负责人王仁果、主管会计工作负责人伯建平及会计机构负责人(会计主

管人员)王晓梅声明:保证季度报告中财务报表的真实、准确、完整。




                                                                                       2
                                                           成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文




                             第二节 主要财务数据及股东变化

一、主要会计数据和财务指标

公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据
□ 是 √ 否

                                       本报告期末                        上年度末                本报告期末比上年度末增减

总资产(元)                                 836,405,554.39                     925,847,048.29                        -9.66%

归属于上市公司股东的净资产
                                             603,432,261.70                     583,350,063.84                         3.44%
(元)

                                                        本报告期比上年同期                                年初至报告期末比上
                                     本报告期                                     年初至报告期末
                                                               增减                                           年同期增减

营业收入(元)                       127,891,227.50                   67.70%           368,926,402.60                 14.74%

归属于上市公司股东的净利润
                                       3,316,362.65                   105.30%           20,082,052.16                134.45%
(元)

归属于上市公司股东的扣除非经
                                       3,215,926.65                   105.12%           19,804,820.89                133.29%
常性损益的净利润(元)

经营活动产生的现金流量净额
                                        --                      --                      14,981,481.77                118.17%
(元)

基本每股收益(元/股)                        0.0077                   105.31%                    0.0466              134.44%

稀释每股收益(元/股)                        0.0077                   105.31%                    0.0466              134.44%

加权平均净资产收益率                            0.55%                  11.09%                    3.38%                13.28%

                                                                                                                     单位:元

                         项目                                  年初至报告期期末金额                         说明

非流动资产处置损益(包括已计提资产减值准备的冲销部分)                             2,059.39

计入当期损益的政府补助(与企业业务密切相关,按照国家统
                                                                                 331,691.07
一标准定额或定量享受的政府补助除外)

除上述各项之外的其他营业外收入和支出                                               -8,843.26

减:所得税影响额                                                                  47,675.93

合计                                                                             277,231.27                   --

对公司根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义界定的非经常性损益项目,以及把《公
开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》中列举的非经常性损益项目界定为经常性损益的项目,应
说明原因
□ 适用 √ 不适用
公司报告期不存在将根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义、列举的非经常性损益
项目界定为经常性损益的项目的情形。


                                                                                                                               3
                                                            成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


二、报告期末股东总数及前十名股东持股情况表

1、普通股股东和表决权恢复的优先股股东总数及前 10 名股东持股情况表

                                                                                                                  单位:股

                                                            报告期末表决权恢复的优先
报告期末普通股股东总数                             35,785                                                              0
                                                            股股东总数(如有)

                                                 前 10 名股东持股情况

                                                                         持有有限售条件          质押或冻结情况
   股东名称         股东性质         持股比例         持股数量
                                                                           的股份数量        股份状态          数量

四川华神集团股
                 境内非国有法人           18.08%         77,923,973                       质押                 13,000,000
份有限公司

王安全           境内自然人                3.49%         15,047,555

聂富全           境内自然人                2.66%            11,462,242

罗国秀           境内自然人                1.83%             7,896,859

丁书干           境内自然人                1.25%             5,400,034

马化勉           境内自然人                1.04%             4,499,531

招商证券股份有
                 境内非国有法人            0.93%             4,030,000
限公司

朱建华           境内自然人                0.87%             3,743,300

赵顺斌           境内自然人                0.79%             3,406,100

林嘉玲           境内自然人                0.50%             2,156,000

                                          前 10 名无限售条件股东持股情况

                                                                                                    股份种类
             股东名称                           持有无限售条件股份数量
                                                                                             股份种类          数量

四川华神集团股份有限公司                                                      77,923,973 人民币普通股          77,923,973

王安全                                                                        15,047,555 人民币普通股          15,047,555

聂富全                                                                        11,462,242 人民币普通股          11,462,242

罗国秀                                                                         7,896,859 人民币普通股           7,896,859

丁书干                                                                         5,400,034 人民币普通股           5,400,034

马化勉                                                                         4,499,531 人民币普通股           4,499,531

招商证券股份有限公司                                                           4,030,000 人民币普通股           4,030,000

朱建华                                                                         3,743,300 人民币普通股           3,743,300

赵顺斌                                                                         3,406,100 人民币普通股           3,406,100

林嘉玲                                                                         2,156,000 人民币普通股           2,156,000

上述股东关联关系或一致行动的      王安全系公司实际控制人、董事长、总裁王仁果的父亲,与公司控股股东四川华神集团



                                                                                                                            4
                                                       成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


说明                             股份有限公司构成一致行动人。上述其余股东之间,公司未知其是否属于《上市公司收
                                 购管理办法》规定的一致行动人。

                                 王安全通过信用交易担保证券账户持有公司股票 15,047,555 股。
                                 聂富全通过信用交易担保证券账户持有公司股票 11,462,242 股。
                                 罗国秀通过信用交易担保证券账户持有公司股票 7,896,859 股。
前 10 名普通股股东参与融资融券
                                 丁书干通过信用交易担保证券账户持有公司股票 5,400,034 股。
业务情况说明(如有)
                                 马化勉通过信用交易担保证券账户持有公司股票 4,499,531 股。
                                 朱建华通过信用交易担保证券账户持有公司股票 3,743,300 股。
                                 赵顺斌通过信用交易担保证券账户持有公司股票 3,380,000 股。

公司前 10 名普通股股东、前 10 名无限售条件普通股股东在报告期内是否进行约定购回交易
□ 是 √ 否
公司前 10 名普通股股东、前 10 名无限售条件普通股股东在报告期内未进行约定购回交易。


2、优先股股东总数及前 10 名优先股股东持股情况表

□ 适用 √ 不适用




                                                                                                                5
                                                     成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文




                                         第三节 重要事项

一、报告期主要会计报表项目、财务指标发生变动的情况及原因

√ 适用 □ 不适用
1、货币资金本报告期末较年初减少11,253.25万元,下降82.08%,主要系偿还到期流动资金贷款11,700.00万元。
2、应收票据本报告期末较年初减少3,134.36万元,下降49.82%,主要系银行承兑汇票背书转让及贴现。
3、预付账款本报告期末较年初增加743.17万元,上升42.38%,主要系公司预付工程款及材料款。
4、其他应收款本报告期末较年初增加566.90万元,上升96.30%,主要系投标保证金及民工保证金增加。
5、短期借款本报告期末较年初减少11,700.00万元,下降75.48%,主要系偿还到期流动资金贷款11,700.00万元。
5、应付票据本报告期末较年初增加563.70万元,上升301.77%,主要系开具商业承兑汇票支付货款。
6、预收账款本报告期末较年初增加1,578.00万元,上升82.10%,主要系钢构公司承接工程项目,预收项目工程款。
7、未分配利润本报告期末较年初增加1,886.41万元,上升51.53%,主要系本报告期盈利增加未分配利润。
8、财务费用年初至本报告期较上年同期减少316.42万元,下降43.87%,主要系本报告期短期流动资金贷款减少。
9、资产减值损失年初至本报告期较上年同期减少2,354.93万元,下降114.85%,主要系钢构公司本报告期计提资产减值同比
减少。
10、营业利润年初至本报告期较上年同期增加8,328.26万元,减亏146.10%,主要系本报告期公司产业结构和产品结构调整,
公司销售规模和综合毛利率同比增加。
11、经营活动产生的现金流量净额本报告期较上年同期增加9,745.08万元,减少赤字118.17%,主要系①本报告期销售商品
提供劳务收到的现金同比增加2,637.76万元;②本报告期购买商品接受劳务支付的现金同比减少6,016.00万元。
12、投资活动产生的现金流量净额本报告期较上年同期减少7,646.50万元,降低109.39%,主要系公司上年同期收到都江堰
土地储备中心拨付土地补偿款7,969万元,本报告期无此类业务收入。
13、筹资活动产生的现金流量净额本报告期较上年同期减少11,213.54万元,降低1272.03%,主要系①年初至本报告期流动
资金贷款所产生的净现金流出同比增加12,700万元;②上年同期支付股利1,154.52万元,本期无此类业务支出。


二、重要事项进展情况及其影响和解决方案的分析说明

√ 适用 □ 不适用
1、关于双流区土地资产开发事宜
2015年4月15日,第十届董事会第十次会议审议通过《关于提请董事会同意授权公司管理层盘活土地资产的议案》,授权公
司管理层选择合适的方式盘活公司位于双流区的土地资产。截至本报告期末,持续开展土地调规工作,启动资产盘活方案研
究工作。
2、关于上海华普钢结构股份有限公司欠款事宜
   2015年5月,子公司四川华神钢构有限责任公司(以下简称“华神钢构”)就与上海华普钢结构股份有限公司(原名上海华
普钢结构工程有限公司)钢构件销售合同纠纷向上海市宝山区人民法院提起诉讼。上海市宝山区人民法院于2015年5月5日出
具[(2015)宝民二(商)初字第1305号]《受理通知书》,决定立案审理。基于谨慎性原则,华神钢构对上海华普钢结构股
份有限公司的应收账款1,474,775.00元全额计提坏账准备。2016年5月18日,上海市宝山区人民法院下达[(2015)宝民二(商)
初字第1305号]民事判决书,判决上海华普钢结构股份有限公司于本判决生效之日起十日内支付四川华神钢构有限责任公司
货款1,401,296.31元,上海华普钢结构股份有限公司于本判决生效之日起十日内支付四川华神钢构有限责任公司利息损失(自
2014年11月1日至实际清偿之日止,以1,401,296.31元为基数,按中国人民银行同期贷款利率计算)。案件受理费17,707元、财
产保全费5,000元均由上海华普钢结构股份有限公司负担。上海华普钢结构股份有限公司不服上海市宝山区人民法院(2015)
宝民二(商)初字第1305号《民事判决书》,上诉至上海市第二中级人民法院。2016年9月27日,在上海市第二中级人民法

                                                                                                             6
                                                          成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


院的主持下,双方就货款偿还相关事宜达成和解协议,上海华普钢结构股份有限公司向华神钢构支付钢构件结算款及诉讼费
用合计1,497,755.75元,支付方式为于2016年9月27日当天以银行承兑汇票方式支付首期款750,000元,剩余款项计747,755. 75
元应于2016年12月20日前以现金方式支付。2016年9月27日,华神钢构已收到上海华普钢结构股份有限公司以银行承兑汇票
方式支付的首期款750,000元。法院将于近期根据双方签订的和解协议制作调解书。
3、董事辞职与增补
   2016年7月,公司董事会收到董事王可澄先生递交的书面辞职申请,王可澄先生因个人原因辞去公司董事及董事会各专
门委员会职务(公告编号:2016-056)。2016年8月,公司2016年第三次临时股东大会增补单喆慜女士为公司董事(公告编
号:2015-063)。

             重要事项概述                              披露日期                      临时报告披露网站查询索引

                                                                               http://www.cninfo.com.cn/cninfo-new/disc
非公开发行股票                          2016 年 09 月 26 日                    losure/szse/bulletin_detail/true/120272266
                                                                               6?announceTime=2016-09-26

                                                                               http://www.cninfo.com.cn/cninfo-new/disc
撤回五龙颗粒注册申请                    2016 年 09 月 30 日                    losure/szse/bulletin_detail/true/120273682
                                                                               3?announceTime=2016-09-30


三、公司、股东、实际控制人、收购人、董事、监事、高级管理人员或其他关联方在报告期
内履行完毕及截至报告期末尚未履行完毕的承诺事项

√ 适用 □ 不适用

            承诺事由               承诺方          承诺类型       承诺内容     承诺时间       承诺期限       履行情况

股改承诺

                                                              除华神集团
                                                              及其控制的
                                                              其他企业外,
                                                              本公司目前
                                                              在中国境内
                                                              外任何地区
                                                              没有以任何
                                                              形式直接或
                                                 关于同业竞   间接从事和
                                 四川泰合置
收购报告书或权益变动报告书中所                   争、关联交   经营与华神     2015 年 08 月
                                 业集团有限                                                  长期          正常履行中
作承诺                                           易、资金占用 集团及其控     31 日
                                 公司
                                                 方面的承诺   制的其他企
                                                              业构成或可
                                                              能构成竞争
                                                              的业务;本公
                                                              司承诺作为
                                                              华神集团控
                                                              股股东期间,
                                                              不在中国境
                                                              内或境外,以



                                                                                                                            7
成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


    任何方式(包
    括但不限于
    单独经营、通
    过合资经营
    或拥有另一
    家公司或企
    业的股权及
    其他权益)直
    接或间接参
    与任何与华
    神集团及其
    控制的其他
    企业构成竞
    争的任何业
    务或活动。本
    公司承诺如
    果违反本承
    诺,愿意向华
    神集团承担
    赔偿及相关
    法律责任。本
    次权益变动
    后泰合集团
    及其关联企
    业将尽量避
    免与上市公
    司之间发生
    关联交易。对
    于无法避免
    的关联交易,
    交易双方将
    按照公开、公
    平、公正的原
    则,合理定
    价,按照市场
    机制进行关
    联交易。泰合
    集团将严格
    按照《公司
    法》等法律法
    规以及《公司
    章程》的有关
    规定行使股
    东权利,除通


                                                      8
                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


                        过合法途径
                        行使股东权
                        利外,不对华
                        神集团的业
                        务活动进行
                        干预,在股东
                        大会涉及关
                        联交易表决
                        时,严格履行
                        回避表决义
                        务,同时按照
                        相关法律法
                        规的规定履
                        行信息披露
                        义务,保证不
                        通过关联交
                        易损害上市
                        公司及其他
                        股东的利益。

                        自本次权益
                        变动完成后,
                        12 个月内不
                        转让本次权
                        益变动取得
                        的上市公司
                        股份。若增持
                        上市公司股
                        份,将按照有
                        关法律法规
                        之要求,履行
四川泰合置              相应的股份
                                       2015 年 08 月
业集团有限   其他承诺   限售承诺。截                   12 个月   履行完毕
                                       31 日
公司                    至本报告书
                        签署之日,泰
                        合集团暂无
                        在未来 12 个
                        月改变华神
                        集团主营业
                        务或对华神
                        集团主营业
                        务作出重大
                        调整的具体
                        计划。如泰合
                        集团未来 12


                                                                            9
成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


    个月内对上
    市公司主营
    业务做出改
    变,泰合集团
    承诺将按照
    有关法律法
    规之要求,履
    行相应的法
    定程序和义
    务。截至本报
    告书签署之
    日,泰合集团
    暂无在未来
    12 个月内对
    上市公司或
    其子公司的
    资产和业务
    进行出售、合
    并、与他人合
    资或合作的
    具体计划,或
    上市公司拟
    购买或置换
    资产的重组
    计划。如果根
    据上市公司
    实际情况需
    要进行资产、
    业务重组,泰
    合集团承诺
    将按照有关
    法律法规之
    要求,履行相
    应的法定程
    序和义务。如
    泰合集团通
    过上述交易
    或重大资产
    重组/配套融
    资增持上市
    公司股份,泰
    合集团承诺
    将按照有关
    法律法规之


                                                     10
                                                       成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


                                                           要求,履行相
                                                           应的法定程
                                                           序和义务。

资产重组时所作承诺

                                                           不越权干预
                                 王仁果、张碧              公司经营管     2016 年 03 月 至 2016 年 12
                                                其他承诺                                                正常履行中
                                 华                        理活动,不侵 10 日           月 31 日
                                                           占公司利益。

                                                           不越权干预
                                 四川华神集
                                                           公司经营管     2016 年 03 月 至 2016 年 12
                                 团股份有限     其他承诺                                                正常履行中
                                                           理活动,不侵 10 日           月 31 日
                                 公司
                                                           占公司利益。

                                                           不无偿或以
                                                           不公平条件
                                                           向其他单位
                                                           或者个人输
                                                           送利益,也不
                                                           采用其他方
                                                           式损害公司
                                                           利益;对董事
                                                           和高级管理
                                                           人员的职务
                                                           消费行为进
首次公开发行或再融资时所作承诺
                                                           行约束;不动
                                 王仁果、王可              用公司资产
                                 澄、黄顺来、              从事与其履
                                 权可富、吴                行职责无关
                                                                          2016 年 03 月 至 2016 年 12
                                 越、谭洪涛、 其他承诺     的投资、消费                                 正常履行中
                                                                          10 日         月 31 日
                                 刘志强、伯建              活动;由董事
                                 平、张文武、              会或薪酬委
                                 曾云莎                    员会制定的
                                                           薪酬制度与
                                                           公司填补回
                                                           报措施的执
                                                           行情况相挂
                                                           钩;拟公布的
                                                           公司股权激
                                                           励的行权条
                                                           件与公司填
                                                           补回报措施
                                                           的执行情况
                                                           相挂钩。相关
                                                           责任主体违


                                                                                                                     11
                                                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


                                                         反承诺或拒
                                                         不履行承诺,
                                                         相关承诺主
                                                         体应在股东
                                                         大会及中国
                                                         证监会指定
                                                         报刊公开作
                                                         出解释并道
                                                         歉,违反承诺
                                                         给公司或者
                                                         股东造成损
                                                         失的,依法承
                                                         担补偿责任。

股权激励承诺

其他对公司中小股东所作承诺

承诺是否按时履行               是


四、对 2016 年度经营业绩的预计

预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生大幅度变动的警示及原因说明
□ 适用 √ 不适用


五、证券投资情况

□ 适用 √ 不适用
公司报告期不存在证券投资。


六、衍生品投资情况

□ 适用 √ 不适用
公司报告期不存在衍生品投资。


七、报告期内接待调研、沟通、采访等活动登记表

√ 适用 □ 不适用

        接待时间                接待方式               接待对象类型               调研的基本情况索引

                                                                         报告期内接听投资者电话数百次,多为
2016 年 09 月 30 日     电话沟通                个人                     投资者问询生产经营及非公开发行等
                                                                         情况。

                                                                         报告期内回复投资者互动易问询二百
2016 年 09 月 30 日     书面问询                个人                     多条,多为投资者问询生产经营和非公
                                                                         开发行等情况。



                                                                                                            12
                                                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


八、违规对外担保情况

□ 适用 √ 不适用
公司报告期无违规对外担保情况。


九、控股股东及其关联方对上市公司的非经营性占用资金情况

□ 适用 √ 不适用
公司报告期不存在控股股东及其关联方对上市公司的非经营性占用资金。




                                                                                                         13
                                                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文




                                        第四节 财务报表

一、财务报表

1、合并资产负债表

编制单位:成都泰合健康科技集团股份有限公司
                                             2016 年 09 月 30 日
                                                                                                      单位:元

                 项目                             期末余额                            期初余额

流动资产:

    货币资金                                                   24,575,749.28                  137,108,292.18

    结算备付金

    拆出资金

    以公允价值计量且其变动计入当期
损益的金融资产

    衍生金融资产

    应收票据                                                   31,565,134.35                     62,908,717.26

    应收账款                                                  335,284,095.17                  274,957,749.69

    预付款项                                                   24,966,223.17                     17,534,507.95

    应收保费

    应收分保账款

    应收分保合同准备金

    应收利息

    应收股利                                                       195,855.78                      195,855.78

    其他应收款                                                 11,555,621.54                      5,886,621.08

    买入返售金融资产

    存货                                                       45,801,492.15                     52,289,735.78

    划分为持有待售的资产

    一年内到期的非流动资产

    其他流动资产

流动资产合计                                                  473,944,171.44                  550,881,479.72

非流动资产:

    发放贷款及垫款



                                                                                                            14
                                     成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


    可供出售金融资产                             100,000.00                       100,000.00

    持有至到期投资

    长期应收款

    长期股权投资                               7,427,794.51                      9,783,186.84

    投资性房地产                              14,443,575.55                     14,989,474.51

    固定资产                                 297,219,646.67                    304,911,655.10

    在建工程

    工程物资

    固定资产清理

    生产性生物资产

    油气资产

    无形资产                                  38,294,229.61                     40,239,153.64

    开发支出                                   2,823,398.88                      2,820,340.07

    商誉

    长期待摊费用                                 825,000.00                       900,000.00

    递延所得税资产                             1,327,737.73                      1,221,758.41

    其他非流动资产

非流动资产合计                               362,461,382.95                    374,965,568.57

资产总计                                     836,405,554.39                    925,847,048.29

流动负债:

    短期借款                                  38,000,000.00                    155,000,000.00

    向中央银行借款

    吸收存款及同业存放

    拆入资金

    以公允价值计量且其变动计入当期
损益的金融负债

    衍生金融负债

    应付票据                                   7,505,000.00                      1,868,000.00

    应付账款                                  83,722,741.15                     91,239,497.58

    预收款项                                  34,999,992.78                     19,219,951.52

    卖出回购金融资产款

    应付手续费及佣金

    应付职工薪酬                               8,069,872.71                     10,960,806.19

    应交税费                                  28,446,655.55                     27,988,951.38




                                                                                           15
                             成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


    应付利息                              50,508.32                       286,677.09

    应付股利                               1,160.44                          1,160.44

    其他应付款                        14,584,445.12                     18,748,398.60

    应付分保账款

    保险合同准备金

    代理买卖证券款

    代理承销证券款

    划分为持有待售的负债

    一年内到期的非流动负债

    其他流动负债                         387,500.00                       387,500.00

流动负债合计                         215,767,876.07                    325,700,942.80

非流动负债:

    长期借款

    应付债券

      其中:优先股

               永续债

    长期应付款

    长期应付职工薪酬

    专项应付款                        14,170,000.00                     13,470,000.00

    预计负债

    递延收益                           3,035,416.62                      3,326,041.65

    递延所得税负债

    其他非流动负债

非流动负债合计                        17,205,416.62                     16,796,041.65

负债合计                             232,973,292.69                    342,496,984.45

所有者权益:

    股本                             431,021,374.00                    431,021,374.00

    其他权益工具

      其中:优先股

               永续债

    资本公积                          38,231,758.60                     38,231,612.90

    减:库存股

    其他综合收益

    专项储备



                                                                                   16
                                                     成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


    盈余公积                                                    78,708,306.12                     77,490,346.08

    一般风险准备

    未分配利润                                                  55,470,822.98                     36,606,730.86

归属于母公司所有者权益合计                                     603,432,261.70                  583,350,063.84

    少数股东权益

所有者权益合计                                                 603,432,261.70                  583,350,063.84

负债和所有者权益总计                                           836,405,554.39                  925,847,048.29


法定代表人:王仁果                     主管会计工作负责人:伯建平                    会计机构负责人:王晓梅


2、母公司资产负债表

                                                                                                       单位:元

                   项目                             期末余额                           期初余额

流动资产:

    货币资金                                                     3,940,835.98                     82,030,858.49

    以公允价值计量且其变动计入当期损
益的金融资产

    衍生金融资产

    应收票据                                                     2,852,056.35                      1,675,611.40

    应收账款                                                    18,595,199.79                     10,787,348.86

    预付款项                                                    16,617,349.88                     16,306,465.49

    应收利息

    应收股利

    其他应收款                                                 225,339,312.81                  211,850,012.90

    存货                                                        23,699,990.30                     26,031,178.40

    划分为持有待售的资产

    一年内到期的非流动资产

    其他流动资产

流动资产合计                                                   291,044,745.11                  348,681,475.54

非流动资产:

    可供出售金融资产                                                100,000.00                      100,000.00

    持有至到期投资

    长期应收款

    长期股权投资                                               210,490,000.00                  210,490,000.00

    投资性房地产                                                14,443,575.55                     14,989,474.51


                                                                                                             17
                                       成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


    固定资产                                   225,192,607.06                    230,497,186.78

    在建工程

    工程物资

    固定资产清理

    生产性生物资产

    油气资产

    无形资产                                    28,291,679.76                     27,670,547.58

    开发支出

    商誉

    长期待摊费用

    递延所得税资产                                 177,160.59                       151,172.18

    其他非流动资产

非流动资产合计                                 478,695,022.96                    483,898,381.05

资产总计                                       769,739,768.07                    832,579,856.59

流动负债:

    短期借款                                    38,000,000.00                     80,000,000.00

    以公允价值计量且其变动计入当期损
益的金融负债

    衍生金融负债

    应付票据                                     7,505,000.00                      1,868,000.00

    应付账款                                    39,614,131.58                     47,149,044.36

    预收款项                                     7,598,923.32                     40,434,835.55

    应付职工薪酬                                 2,110,574.67                      3,407,602.56

    应交税费                                     9,819,920.85                      9,768,652.23

    应付利息                                        50,508.32                       165,145.42

    应付股利                                         1,160.44                          1,160.44

    其他应付款                                   7,571,308.53                     10,202,318.46

    划分为持有待售的负债

    一年内到期的非流动负债

    其他流动负债                                   387,500.00                       387,500.00

流动负债合计                                   112,659,027.71                    193,384,259.02

非流动负债:

    长期借款

    应付债券




                                                                                             18
                                   成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


      其中:优先股

               永续债

    长期应付款

    长期应付职工薪酬

    专项应付款                                   3,700,000.00                    3,000,000.00

    预计负债

    递延收益                                     3,035,416.62                    3,326,041.65

    递延所得税负债

    其他非流动负债

非流动负债合计                                   6,735,416.62                    6,326,041.65

负债合计                                       119,394,444.33                  199,710,300.67

所有者权益:

    股本                                       431,021,374.00                  431,021,374.00

    其他权益工具

      其中:优先股

               永续债

    资本公积                                    69,679,927.77                   69,679,782.07

    减:库存股

    其他综合收益

    专项储备

    盈余公积                                    78,708,306.12                   77,490,346.08

    未分配利润                                  70,935,715.85                   54,678,053.77

所有者权益合计                                 650,345,323.74                  632,869,555.92

负债和所有者权益总计                           769,739,768.07                  832,579,856.59


3、合并本报告期利润表

                                                                                     单位:元

                 项目         本期发生额                          上期发生额

一、营业总收入                             127,891,227.50                       76,263,067.88

    其中:营业收入                         127,891,227.50                       76,263,067.88

           利息收入

           已赚保费

           手续费及佣金收入

二、营业总成本                             121,558,950.41                      139,589,875.40



                                                                                           19
                                      成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


    其中:营业成本                         57,248,004.84                         41,600,739.48

             利息支出

             手续费及佣金支出

             退保金

             赔付支出净额

             提取保险合同准备金净额

             保单红利支出

             分保费用

             营业税金及附加                 2,656,747.59                          1,547,868.74

             销售费用                      40,826,600.08                         39,166,709.94

             管理费用                      20,589,172.90                         31,177,173.17

             财务费用                         898,664.78                          2,242,401.55

             资产减值损失                    -660,239.78                         23,854,982.52

    加:公允价值变动收益(损失以
“-”号填列)

         投资收益(损失以“-”号填
                                             -779,023.29                           443,717.62
列)

             其中:对联营企业和合营
                                             -779,023.29                             -1,397.00
企业的投资收益

         汇兑收益(损失以“-”号填
列)

三、营业利润(亏损以“-”号填列)          5,553,253.80                        -62,883,089.90

    加:营业外收入                            118,041.07                           200,495.93

         其中:非流动资产处置利得

    减:营业外支出                              1,573.80                              2,052.76

         其中:非流动资产处置损失                                                     2,051.26

四、利润总额(亏损总额以“-”号填
                                            5,669,721.07                        -62,684,646.73
列)

    减:所得税费用                          2,353,358.42                           -126,119.51

五、净利润(净亏损以“-”号填列)          3,316,362.65                        -62,558,527.22

    归属于母公司所有者的净利润              3,316,362.65                        -62,558,527.22

    少数股东损益

六、其他综合收益的税后净额

  归属母公司所有者的其他综合收益
的税后净额

    (一)以后不能重分类进损益的


                                                                                            20
                                                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


其他综合收益

             1.重新计量设定受益计划
净负债或净资产的变动

             2.权益法下在被投资单位
不能重分类进损益的其他综合收益中
享有的份额

    (二)以后将重分类进损益的其
他综合收益

             1.权益法下在被投资单位
以后将重分类进损益的其他综合收益
中享有的份额

             2.可供出售金融资产公允
价值变动损益

             3.持有至到期投资重分类
为可供出售金融资产损益

             4.现金流量套期损益的有
效部分

             5.外币财务报表折算差额

             6.其他

  归属于少数股东的其他综合收益的
税后净额

七、综合收益总额                                            3,316,362.65                        -62,558,527.22

    归属于母公司所有者的综合收益
                                                            3,316,362.65                        -62,558,527.22
总额

    归属于少数股东的综合收益总额

八、每股收益:

    (一)基本每股收益                                           0.0077                               -0.1451

    (二)稀释每股收益                                           0.0077                               -0.1451

本期发生同一控制下企业合并的,被合并方在合并前实现的净利润为:元,上期被合并方实现的净利润为:元。


法定代表人:王仁果                    主管会计工作负责人:伯建平                    会计机构负责人:王晓梅


4、母公司本报告期利润表

                                                                                                      单位:元

                 项目                         本期发生额                           上期发生额

一、营业收入                                               45,315,852.56                        30,463,006.41

    减:营业成本                                           26,624,487.28                        19,343,667.01



                                                                                                            21
                                      成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


         营业税金及附加                       460,112.34                           511,051.47

         销售费用                           5,605,336.38                         16,815,787.80

         管理费用                           5,725,973.50                          8,140,952.98

         财务费用                             732,686.85                          1,121,759.44

         资产减值损失

    加:公允价值变动收益(损失以
“-”号填列)

         投资收益(损失以“-”号填
列)

         其中:对联营企业和合营企
业的投资收益

二、营业利润(亏损以“-”号填列)          6,167,256.21                        -15,470,212.29

    加:营业外收入                             96,875.03                           195,495.93

         其中:非流动资产处置利得

    减:营业外支出                                                                    2,051.26

         其中:非流动资产处置损失                                                     2,051.26

三、利润总额(亏损总额以“-”号填
                                            6,264,131.24                        -15,276,767.62
列)

    减:所得税费用                            965,210.02                         -7,406,497.96

四、净利润(净亏损以“-”号填列)          5,298,921.22                         -7,870,269.66

五、其他综合收益的税后净额

    (一)以后不能重分类进损益的
其他综合收益

             1.重新计量设定受益计划
净负债或净资产的变动

             2.权益法下在被投资单位
不能重分类进损益的其他综合收益中
享有的份额

    (二)以后将重分类进损益的其
他综合收益

             1.权益法下在被投资单位
以后将重分类进损益的其他综合收益
中享有的份额

             2.可供出售金融资产公允
价值变动损益

             3.持有至到期投资重分类
为可供出售金融资产损益



                                                                                            22
                                           成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


           4.现金流量套期损益的有
效部分

           5.外币财务报表折算差额

           6.其他

六、综合收益总额                                     5,298,921.22                       -7,870,269.66

七、每股收益:

    (一)基本每股收益

    (二)稀释每股收益


5、合并年初到报告期末利润表

                                                                                             单位:元

                 项目                 本期发生额                          上期发生额

一、营业总收入                                     368,926,402.60                      321,522,581.68

    其中:营业收入                                 368,926,402.60                      321,522,581.68

           利息收入

           已赚保费

           手续费及佣金收入

二、营业总成本                                     340,290,342.49                      378,967,441.88

    其中:营业成本                                 155,236,258.16                      164,156,532.36

           利息支出

           手续费及佣金支出

           退保金

           赔付支出净额

           提取保险合同准备金净额

           保单红利支出

           分保费用

           营业税金及附加                            4,300,690.87                        3,766,693.27

           销售费用                                130,485,146.74                      117,033,013.20

           管理费用                                 49,262,984.00                       66,292,481.79

           财务费用                                  4,049,282.35                        7,213,474.89

           资产减值损失                             -3,044,019.63                       20,505,246.37

    加:公允价值变动收益(损失以
“-”号填列)

         投资收益(损失以“-”号填
                                                    -2,355,392.33                         442,944.60
列)


                                                                                                   23
                                      成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


         其中:对联营企业和合营企
                                            -2,355,392.33                            -2,170.02
业的投资收益

         汇兑收益(损失以“-”号填
列)

三、营业利润(亏损以“-”号填列)         26,280,667.78                        -57,001,915.60

    加:营业外收入                            344,817.47                          1,471,387.93

         其中:非流动资产处置利得              13,126.40

    减:营业外支出                             19,910.27                           131,286.65

         其中:非流动资产处置损失              11,067.01                             9,017.89

四、利润总额(亏损总额以“-”号填
                                           26,605,574.98                        -55,661,814.32
列)

    减:所得税费用                          6,523,522.82                          2,637,864.99

五、净利润(净亏损以“-”号填列)         20,082,052.16                        -58,299,679.31

    归属于母公司所有者的净利润             20,082,052.16                        -58,299,679.31

    少数股东损益

六、其他综合收益的税后净额

  归属母公司所有者的其他综合收益
的税后净额

    (一)以后不能重分类进损益的
其他综合收益

             1.重新计量设定受益计划
净负债或净资产的变动

             2.权益法下在被投资单位
不能重分类进损益的其他综合收益中
享有的份额

    (二)以后将重分类进损益的其
他综合收益

             1.权益法下在被投资单位
以后将重分类进损益的其他综合收益
中享有的份额

             2.可供出售金融资产公允
价值变动损益

             3.持有至到期投资重分类
为可供出售金融资产损益

             4.现金流量套期损益的有
效部分

             5.外币财务报表折算差额



                                                                                            24
                                                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


             6.其他

  归属于少数股东的其他综合收益的
税后净额

七、综合收益总额                                            20,082,052.16                       -58,299,679.31

    归属于母公司所有者的综合收益
                                                            20,082,052.16                       -58,299,679.31
总额

    归属于少数股东的综合收益总额

八、每股收益:

    (一)基本每股收益                                            0.0466                               -0.1353

    (二)稀释每股收益                                            0.0466                               -0.1353

本期发生同一控制下企业合并的,被合并方在合并前实现的净利润为:元,上期被合并方实现的净利润为:元。


6、母公司年初到报告期末利润表

                                                                                                      单位:元

                 项目                         本期发生额                           上期发生额

一、营业收入                                               159,023,793.66                       144,954,132.46

    减:营业成本                                            94,582,262.39                        93,998,575.20

           营业税金及附加                                    1,976,892.27                         1,562,138.26

           销售费用                                         21,715,539.68                        25,729,936.00

           管理费用                                         17,507,641.27                        21,914,135.86

           财务费用                                          2,783,985.18                         4,022,140.29

           资产减值损失                                       174,893.44                         -3,961,180.63

    加:公允价值变动收益(损失以
“-”号填列)

           投资收益(损失以“-”号填
列)

           其中:对联营企业和合营企
业的投资收益

二、营业利润(亏损以“-”号填列)                          20,282,579.43                         1,688,387.48

    加:营业外收入                                            323,651.43                           776,387.93

           其中:非流动资产处置利得                             13,126.40

    减:营业外支出                                              15,811.88                          131,101.65

           其中:非流动资产处置损失                              8,615.19                             6,783.13

三、利润总额(亏损总额以“-”号填
                                                            20,590,418.98                         2,333,673.76
列)




                                                                                                            25
                                           成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


     减:所得税费用                                  3,114,796.86                       -4,764,931.75

四、净利润(净亏损以“-”号填列)                  17,475,622.12                        7,098,605.51

五、其他综合收益的税后净额

     (一)以后不能重分类进损益的
其他综合收益

             1.重新计量设定受益计划
净负债或净资产的变动

             2.权益法下在被投资单位
不能重分类进损益的其他综合收益中
享有的份额

     (二)以后将重分类进损益的其
他综合收益

             1.权益法下在被投资单位
以后将重分类进损益的其他综合收益
中享有的份额

             2.可供出售金融资产公允
价值变动损益

             3.持有至到期投资重分类
为可供出售金融资产损益

             4.现金流量套期损益的有
效部分

             5.外币财务报表折算差额

             6.其他

六、综合收益总额                                    17,475,622.12                        7,098,605.51

七、每股收益:

     (一)基本每股收益

     (二)稀释每股收益


7、合并年初到报告期末现金流量表

                                                                                             单位:元

                 项目                 本期发生额                          上期发生额

一、经营活动产生的现金流量:

     销售商品、提供劳务收到的现金                  314,939,799.93                      288,562,155.55

     客户存款和同业存放款项净增加


     向中央银行借款净增加额




                                                                                                   26
                                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


     向其他金融机构拆入资金净增加


     收到原保险合同保费取得的现金

     收到再保险业务现金净额

     保户储金及投资款净增加额

     处置以公允价值计量且其变动计
入当期损益的金融资产净增加额

     收取利息、手续费及佣金的现金

     拆入资金净增加额

     回购业务资金净增加额

     收到的税费返还

     收到其他与经营活动有关的现金         1,232,284.78                          5,157,191.06

经营活动现金流入小计                    316,172,084.71                        293,719,346.61

     购买商品、接受劳务支付的现金        56,718,655.65                        116,878,665.84

     客户贷款及垫款净增加额

     存放中央银行和同业款项净增加


     支付原保险合同赔付款项的现金

     支付利息、手续费及佣金的现金

     支付保单红利的现金

     支付给职工以及为职工支付的现
                                         44,345,573.97                         56,239,460.60


     支付的各项税费                      56,978,701.85                         72,670,338.61

     支付其他与经营活动有关的现金       143,147,671.47                        130,400,205.36

经营活动现金流出小计                    301,190,602.94                        376,188,670.41

经营活动产生的现金流量净额               14,981,481.77                        -82,469,323.80

二、投资活动产生的现金流量:

     收回投资收到的现金

     取得投资收益收到的现金

     处置固定资产、无形资产和其他
                                             45,000.00                         79,732,062.00
长期资产收回的现金净额

     处置子公司及其他营业单位收到
                                                                                  113,032.77
的现金净额

     收到其他与投资活动有关的现金           208,388.93                           455,662.63

投资活动现金流入小计                        253,388.93                         80,300,757.40

     购建固定资产、无形资产和其他         6,816,494.91                         10,398,882.98


                                                                                          27
                                         成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


长期资产支付的现金

    投资支付的现金

    质押贷款净增加额

    取得子公司及其他营业单位支付
的现金净额

    支付其他与投资活动有关的现金

投资活动现金流出小计                               6,816,494.91                       10,398,882.98

投资活动产生的现金流量净额                        -6,563,105.98                       69,901,874.42

三、筹资活动产生的现金流量:

    吸收投资收到的现金

    其中:子公司吸收少数股东投资
收到的现金

    取得借款收到的现金                                                               117,000,000.00

    发行债券收到的现金

    收到其他与筹资活动有关的现金

筹资活动现金流入小计                                                                 117,000,000.00

    偿还债务支付的现金                           117,000,000.00                      107,000,000.00

    分配股利、利润或偿付利息支付
                                                   3,550,918.69                       18,815,473.59
的现金

    其中:子公司支付给少数股东的
股利、利润

    支付其他与筹资活动有关的现金                    400,000.00

筹资活动现金流出小计                             120,950,918.69                      125,815,473.59

筹资活动产生的现金流量净额                   -120,950,918.69                          -8,815,473.59

四、汇率变动对现金及现金等价物的
影响

五、现金及现金等价物净增加额                 -112,532,542.90                         -21,382,922.97

    加:期初现金及现金等价物余额                 137,108,292.18                      130,005,682.93

六、期末现金及现金等价物余额                      24,575,749.28                      108,622,759.96


8、母公司年初到报告期末现金流量表

                                                                                           单位:元

              项目                  本期发生额                          上期发生额

一、经营活动产生的现金流量:

    销售商品、提供劳务收到的现金                  87,767,676.90                      137,042,810.10



                                                                                                 28
                                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


     收到的税费返还

     收到其他与经营活动有关的现金         1,070,331.43                          4,081,479.29

经营活动现金流入小计                     88,838,008.33                        141,124,289.39

     购买商品、接受劳务支付的现金        28,479,651.70                         31,782,974.53

     支付给职工以及为职工支付的现
                                         19,687,965.73                         26,292,381.52


     支付的各项税费                      22,334,088.84                         39,560,094.38

     支付其他与经营活动有关的现金        27,712,938.53                         36,367,402.56

经营活动现金流出小计                     98,214,644.80                        134,002,852.99

经营活动产生的现金流量净额                -9,376,636.47                         7,121,436.40

二、投资活动产生的现金流量:

     收回投资收到的现金

     取得投资收益收到的现金

     处置固定资产、无形资产和其他
                                             45,000.00                         79,732,062.00
长期资产收回的现金净额

     处置子公司及其他营业单位收到
的现金净额

     收到其他与投资活动有关的现金           152,663.12                           363,419.89

投资活动现金流入小计                        197,663.12                         80,095,481.89

     购建固定资产、无形资产和其他
                                          6,697,720.75                          9,881,429.20
长期资产支付的现金

     投资支付的现金

     取得子公司及其他营业单位支付
的现金净额

     支付其他与投资活动有关的现金        17,500,000.00                         67,075,120.00

投资活动现金流出小计                     24,197,720.75                         76,956,549.20

投资活动产生的现金流量净额               -24,000,057.63                         3,138,932.69

三、筹资活动产生的现金流量:

     吸收投资收到的现金

     取得借款收到的现金                                                        42,000,000.00

     发行债券收到的现金

     收到其他与筹资活动有关的现金

筹资活动现金流入小计                                                           42,000,000.00

     偿还债务支付的现金                  42,000,000.00                         42,000,000.00

     分配股利、利润或偿付利息支付
                                          2,313,328.41                         15,468,847.47
的现金


                                                                                          29
                                    成都泰合健康科技集团股份有限公司 2016 年第三季度报告全文


     支付其他与筹资活动有关的现金           400,000.00

筹资活动现金流出小计                     44,713,328.41                         57,468,847.47

筹资活动产生的现金流量净额               -44,713,328.41                       -15,468,847.47

四、汇率变动对现金及现金等价物的
影响

五、现金及现金等价物净增加额             -78,090,022.51                        -5,208,478.38

     加:期初现金及现金等价物余额        82,030,858.49                         53,453,135.87

六、期末现金及现金等价物余额              3,940,835.98                         48,244,657.49


二、审计报告

第三季度报告是否经过审计
□ 是 √ 否
公司第三季度报告未经审计。




                                                                                          30
数据加载中...
prevnext
手机查看股票